¡Ya estamos en !
Descubre más
Celularity Inc
Excluida de cotización
CELUW dejó de cotizar en bolsa el 17 de julio de 2026.
Acerca de: Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Empleados: 115
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
No hemos recibido artículos de noticias recientes sobre CELUW.
Gráficos de precios implementados con Lightweight Charts™